Article Text
Abstract
Increasingly, bioethicists defend informed consent as a safeguard for trust in caretakers and medical institutions. This paper discusses an ‘ideal type’ of that move. What I call the trust-promotion argument for informed consent states:
1. Social trust, especially trust in caretakers and medical institutions, is necessary so that, for example, people seek medical advice, comply with it, and participate in medical research.
2. Therefore, it is usually wrong to jeopardise that trust.
3. Coercion, deception, manipulation and other violations of standard informed consent requirements seriously jeopardise that trust.
4. Thus, standard informed consent requirements are justified.
This article describes the initial promise of this argument, then identifies challenges to it. As I show, the value of trust fails to account for some commonsense intuitions about informed consent. We should revise the argument, commonsense morality, or both.
- Coercion
- Informed Consent
- Truth Disclosure
- Right to Refuse Treatment
Statistics from Altmetric.com
Linked Articles
- Commentary
- Commentary
- Commentary
- The concise argument
Other content recommended for you
- Understanding public trust in services provided by community pharmacists relative to those provided by general practitioners: a qualitative study
- Too much medicine: not enough trust? A response
- Trust, trustworthiness and sharing patient data for research
- The unintended consequences of COVID-19 vaccine policy: why mandates, passports and restrictions may cause more harm than good
- Informed consent, the value of trust, and hedons
- To see for myself: informed consent and the culture of openness
- How did rapid scale-up of HIV services impact on workplace and interpersonal trust in Zambian primary health centres: a case-based health systems analysis
- Healthcare distrust among hospitalised black patients during the COVID-19 pandemic
- Development and validation of a socioculturally competent trust in physician scale for a developing country setting
- Accessing medical biobanks to solve crimes: ethical considerations